Transforming growth factor-f (TGF, 8) (J. Clin. Invest. 1992. 90:35-41.)
Introduction
Members of the transforming growth factor-f (TGF3)' family of signaling peptides are released from platelets and produced by many cell types in culture including macrophages, monocytes (1), neutrophils (2), T lymphocytes (3) , and fibroblasts (4). These peptides have a variety of inflammatory and immunomodulatory effects, and alter the growth and function of a wide variety of cells (5) . TGFJ3 appears to play an important part in the pathogenesis of fibrosis, since these peptides stimu- 1 . Abbreviations used in this paper: CMF, calcium-and magnesiumfree; 4aPDB, 4-a-phorbol 12, 13-dibutyrate; GAP, glyceraldehyde 3-phosphate dehydrogenase; TGFf, transforming growth factor-,B.
late production of extracellular matrix (6, 7) and inhibit the formation of extracellular proteases (8) . In animal models of pulmonary fibrosis, large increases in TGF,# are seen shortly before fibrosis begins (9-1 1) . Finally, abnormally large amounts of TGFO are observed in clinical specimens obtained from humans with fibrotic diseases of the lung (12, 13) , eye (14) , joints (15) , and skin (16) .
Mast cells, in addition to the well-known part they play in allergic reactions, may contribute to the pathogenesis of a variety of nonallergic inflammatory conditions (17) . In particular, histologic observations have led to the hypothesis that mast cells play an important part in many fibrotic reactions (18) (19) (20) (21) (22) (23) (24) (25) (26) . Potential mast cell-derived mediators of the fibrotic response include the mast cell protease tryptase, which has recently been found to stimulate fibroblast proliferation (27) , as well as a partially characterized fibroblast growth-stimulating activity distinct both from tryptase and from TGFB (28) . Despite these observations, mast cells are not known to elaborate mediators capable of inducing extracellular matrix deposition. We have characterized previously four dog mastocytoma cell lines (29) (30) (31) . Despite their neoplastic phenotype, these cells display a number of mast cell-specific characteristics. They express high affinity IgE receptors and beta-adrenergic receptors, and release typical mast cell mediators including histamine, proteases, prostaglandins, leukotrienes, and proteoglycans in response to specific antigen or calcium ionophore. To examine the role of mast cells in fibrotic reactions, we addressed the hypothesis that mast cells produce fibrogenic peptide growth factors. We report here that mastocytoma cells secrete TGF (31. We suggest that mast cells, by producing TGFfl1, may contribute to the pathogenesis of inflammation and fibrosis.
Methods
Materials. Unless specified, all chemicals were from Sigma Chemical Co. (St. Louis, MO). Phorbol myristate acetate (PMA) was obtained from ICN Biochemicals, Cleveland, OH, and 4-a-phorbol 12,1 3-dibutyrate (4aPDB) from LC Services, Woburn, MA. TGF#3, TGF32, anti-TGF3, and anti-TGFf32 were purchased from R&D Systems, Inc., Minneapolis, MN.
Cell culture. Mastocytoma cells were maintained in passage in tissue culture (C,, C2, and BR cell lines) or in athymic nude mice (G and BR cell lines). The cell lines proliferate in tissue culture in DME H 16 mixed 50% with Ham's F12 supplemented with 2% dog or calf serum, penicillin (100 U/ml), streptomycin (100 ,g/ml), 2 mM glutamine, 1.6 mM histidine, 25 mM Hepes (pH 7.4) (normal growth medium). Cells maintained in this medium were split 1:4 at weekly intervals. Mastocytoma cells were dissociated from nude mouse tumors by digestion with collagenase as previously reported (30, 31) .
CCL-64 (Mv lLu) mink lung epithelial cells were obtained from American Type Culture Collection, Rockville, MD, and were maintained in DME supplemented with 10% calf serum. All cells were maintained at 37°C in 5% CO2. Collection ofconditioned media. Cultured mastocytoma cells growing in log phase in normal growth medium were washed twice with calcium-and magnesium-free (CMF) PBS and resuspended overnight at 4 x 106 cells/ml in a T-150 flask (Corning Glass Inc., Corning, NY) in collection medium (normal growth medium except that BSA, 1-2 mg/ml, was substituted for serum). The following day cells were washed once more with CMF PBS and then suspended at the same density in collection medium. After 48 h, the media were collected and centrifuged at 800 g for 5 min to remove suspended cells and debris and the conditioned media were stored at -20'C. For the G and BR cell lines, conditioned media were collected for 48 h after disaggregation from athymic nude mouse tumors. In some experiments, proteinase inhibitors (soybean trypsin inhibitor, aprotinin, leupeptin, and phosphoramidon, each at 20 ,ug/ml) were added to the collection media.
Time Boehringer Mannheim Corp., Indianapolis, IN) and exposed to radiographic film. RNA isolation and separation. RNA was purified from cultured BR and C2 cells by CsCl gradient centrifugation followed by phenol/chloroform extraction and ethanol precipitation (35) . Polyadenylated RNA was prepared by oligo deoxythymidine chromatography (36) . For comparison, RNA was also harvested directly from mastocytomas grown in athymic nude mice, from liver, spleen, and PBMC obtained from healthy adult dogs, and from early passage dog skin fibroblasts grown in culture in 10% CS-supplemented medium. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In the presence of anti-TGFf3 (chicken IgY; R&D Systems), the TGFfl effect in 30-min supernatants was completely reversed (n = 3). Control cultures treated in parallel with the inactive phorbol ester 4aPDB (n = 2) or with DMSO (n = 4) released TGFf activity at a rate indistinguishable from untreated cells (Fig. 4) . As with unstimulated cells, TGFf was released primarily (> 95%) in a latent form after PMA stimulation.
TGFf3 mRNA studies. RNA blot analysis was done to confirm the presence of TGFB mRNA and to further determine which ofthe isoforms ofTGFfl were produced by mastocytoma cells. Cultured BR and C2 cells constitutively expressed mRNA for TGF#3 in amounts that were easily detectable in total cellu- at concentrations of 0.6-1.0 pM were found to inhibit 50% of baseline thymidine incorporation in CCL-64 cells under the experimental conditions described. Each of the four mastocytoma cell lines also produced growth-inhibitory activity, with concentration-response curves paralleling that of pure TGFJ3, (Fig. 1 A) . The amount of TGFf activity produced by the BR, G, and C2 cell lines was similar (media conditioned for 48 h by 4 X 106 cells/ml contained -4 ng/ml TGFO). The C, cell line produced two-to fourfold less activity.
To determine whether mastocytoma cells secreted TGF3 in a biologically active form, samples were tested with or without transient acidification. Minimal growth-inhibitory activity was seen without acidification (Fig. 1 B) . This small amount of activity occurred in samples containing high concentrations of latent TGFf, and represented < 5% of the activity attainable after acidification. The addition of protease inhibitors to the collection media did not change the proportion ofactive TGFO detected, nor did it affect the total amount ofactivity recovered by acidification (data not shown).
Neutralizing antibody against TGF3 (with activity against both TGFf1 and TGFf32) blocked 90% ofthe growth-inhibitory activity in a concentration-dependent manner (Fig. 2 ). An antibody specific for TGFj2 caused no detectable blockade. The specificity of these antibodies was confirmed using purified TGFOI and TGFf2 (data not shown). Identification of the growth-inhibitory activity as TGF3 was confirmed by western blot (Fig. 3) . When probed with anti-TGFg, C2 and BR cell extracts gave a band with similar migration to that of pure porcine TGFO3 under reducing conditions. thesis (to approximately 10% ofthe control value) was achieved by treatment with 100 pM TGFf#1 (Fig. 6 ). This effect was reproduced by acidified C2 cell-conditioned medium with a concentration-response curve parallel to that for pure TGF31.
As in the CCL-64 cell assay, minimal inhibition of mitogenesis was observed with C2 cell-conditioned medium unless it was first transiently acidified. Proliferation experiments using the C1 and C2 cell lines in 0.2% allergic dog serum-supplemented medium revealed growth ofcells with doubling times of42 and 38 h, respectively. (Fig. 6) .
Discussion
We have shown that dog mastocytoma cells produce TGF#3, as determined by biologic activity, blockade of the biological effect by specific neutralizing antibody, and characteristic migration and antibody recognition on western blot. min after stimulation, without increasing TGFf,3 mRNA. We also found that pure TGFf3, inhibited mastocytoma cell DNA synthesis and cellular proliferation, and mastocytoma cell mitogenesis was inhibited by its own conditioned medium, once the conditioned medium was transiently acidified.
Mast cells are seen in greatly increased numbers in fibrotic lung tissue (18) , in the involved skin in scleroderma (20) , and in the synovium in rheumatoid arthritis (43) . Induction ofpulmonary fibrosis in animals by exposure to asbestos, bleomycin, or irradiation also results in mast cell activation and accumulation (21, 22, 23, 44) . Murine mast cells studied in vitro stimulate fibroblast growth and synthesis of collagen and proteoglycan (25) by an unknown mechanism. By producing TGFflI, mast cells may induce connective tissue deposition, and thereby contribute to tissue fibrosis.
TGFB is released from platelets and from most cells in a high molecular weight, latent form which does not bind its receptor and is not biologically active (45) . Enzymes such as plasmin, cathepsin D, and endoglycosidase F release a fraction of the active factor in vitro (46, 47) . Acidification is a convenient method for activation of TGF3 in vitro, although the pH required ( 2) makes this mechanism of activation unlikely to Dog Mastocytoma Cells Produce Transforming Growth Factor Beta, 39 I occur in vivo. The physiologic activation of this peptide, presumably by proteolytic event(s), is considered an important regulatory mechanism. Mastocytoma cells released TGFI3 primarily in a latent form, although small proportions (< 5%) of TGF,3 activity could often be detected before acidification. It is unclear whether mastocytoma cells actually release a small amount of active TGFf, whether activation occurs during manipulation, (e.g., freezing and thawing, as has been previously reported [46] ), or whether high molecular weight ("latent" TGF,3 may have a small degree ofintrinsic biologic activity, as suggested (48) . Thus complete understanding of the contribution of mast cell-derived TGF# must await better information regarding the control of TGFf activation from the latent complex.
The three isoforms of TGFf found in mammalian systems are structurally related molecules whose receptor binding and biological properties are similar (33) (20-23, 43, 51) . Proliferation of murine mast cells in vitro is stimulated by IL-3, IL-4, IL-9, and steel factor (52-55) whereas growth is inhibited by TGFj1 (42) and granulocyte macrophage-colony-stimulating factor (GM-CSF) (56) . It has been suggested previously that mast cells themselves may produce agents which limit mast cell proliferation or differentiation, and that GM-CSF may be a candidate mediator for this action (56, 57) . Our results indicate that TGFI31 must also be considered a possible mast cell autocrine growth inhibitor. Indeed, a recent report indicates that the mast cell growth response to IL-3 and IL-4 is inhibited by phorbol ester (58); it is possible that mast cell production of TGFf may be involved in this growth inhibition. This is not a classical autocrine loop, however, since the peptide is released in a latent form which must be activated, possibly by a second cell type, before it inhibits mast cell growth. TGF(3 production seems not to be an artifact ofcell culture, since TGFI,3 mRNA is expressed not only in cell culture, but in vivo in mast cell tumors as they grow in athymic nude mice. Similarly, TGF,3 activity is released from cells both immediately after disaggregation from athymic nude mouse tumors and after prolonged culture in vitro.
In summary, we have shown that dog mastocytoma cells produce TGFj31. This is the first evidence ofTGF(3 production by mast-like cells. These findings suggest a mechanism by which mast cells may contribute to inflammatory and fibrotic reactions in many tissues and further suggests a possible autocrine regulatory role for TGF#,/ in mast cell proliferation.
